BACKGROUND: It is not known whether cardiovascular disease (CVD) risk level is related to knowledge of the leading cause of death of women or heart attack symptoms. HYPOTHESIS: Women with higher CVD risk estimated by Framingham Risk Score (FRS) or metabolic syndrome (MS) have lower CVD knowledge. METHODS: Women visiting primary care clinics completed a standardized behavioral risk questionnaire. Blood pressure, weight, height, waist size, fasting glucose, and lipid profile were assessed. Women were queried regarding CVD knowledge. RESULTS: Participants (N = 823) were Hispanic women (46%), non-Hispanic white (37%), and non-Hispanic black (8%). FRS was determined in 278: low (63%), moderate (29%), and high (8%); 24% had ≥3 components of MS. The leading cause of death was answered correctly by 54%, heart attack symptoms by 67%. Knowledge was lowest among racial/ethnic minorities and those with less education (both P< 0.001). Increasing FRS was inversely associated with knowing the leading cause of death (low 72%, moderate 68%, high 45%, P = 0.045). After multivariable adjustment, moderate/high FRS was inversely associated with knowing symptoms (moderate odds ratio [OR] 0.52, 95% confidence interval [CI]: 0.28-0.98; high OR 0.29, 95% CI: 0.11-0.81), but not the leading cause of death. MS was inversely associated with knowing the leading cause of death (P< 0.001) or heart attack symptoms (P = 0.018), but not after multivariable adjustment. CONCLUSIONS: Women with higher FRS were less likely to know heart attack symptoms. Efforts to target those at higher CVD risk must persist, or the most vulnerable may suffer disproportionately, not only because of risk factors but also inadequate knowledge.
BACKGROUND: It is not known whether cardiovascular disease (CVD) risk level is related to knowledge of the leading cause of death of women or heart attack symptoms. HYPOTHESIS: Women with higher CVD risk estimated by Framingham Risk Score (FRS) or metabolic syndrome (MS) have lower CVD knowledge. METHODS:Women visiting primary care clinics completed a standardized behavioral risk questionnaire. Blood pressure, weight, height, waist size, fasting glucose, and lipid profile were assessed. Women were queried regarding CVD knowledge. RESULTS:Participants (N = 823) were Hispanic women (46%), non-Hispanic white (37%), and non-Hispanic black (8%). FRS was determined in 278: low (63%), moderate (29%), and high (8%); 24% had ≥3 components of MS. The leading cause of death was answered correctly by 54%, heart attack symptoms by 67%. Knowledge was lowest among racial/ethnic minorities and those with less education (both P< 0.001). Increasing FRS was inversely associated with knowing the leading cause of death (low 72%, moderate 68%, high 45%, P = 0.045). After multivariable adjustment, moderate/high FRS was inversely associated with knowing symptoms (moderate odds ratio [OR] 0.52, 95% confidence interval [CI]: 0.28-0.98; high OR 0.29, 95% CI: 0.11-0.81), but not the leading cause of death. MS was inversely associated with knowing the leading cause of death (P< 0.001) or heart attack symptoms (P = 0.018), but not after multivariable adjustment. CONCLUSIONS:Women with higher FRS were less likely to know heart attack symptoms. Efforts to target those at higher CVD risk must persist, or the most vulnerable may suffer disproportionately, not only because of risk factors but also inadequate knowledge.
Authors: Mark A Veazie; James M Galloway; Dyann Matson-Koffman; Darwin R LaBarthe; J Nell Brownstein; Marian Emr; Eric Bolton; Eugene Freund; Robinson Fulwood; Jeanette Guyton-Krishnan; Yuling Hong; Michael Lebowitz; Emmeline Ochiai; Mark Schoeberl; Rose Marie Robertson Journal: Circulation Date: 2005-10-18 Impact factor: 29.690
Authors: Adesuwa B Olomu; Mary Grzybowski; Vijay S Ramanath; Adam M Rogers; Bonnie Motyka Vautaw; Benrong Chen; Canopy Roychoudhury; Elizabeth A Jackson; Kim A Eagle Journal: Am Heart J Date: 2010-03 Impact factor: 4.749
Authors: R V Luepker; J M Raczynski; S Osganian; R J Goldberg; J R Finnegan; J R Hedges; D C Goff; M S Eisenberg; J G Zapka; H A Feldman; D R Labarthe; P G McGovern; C E Cornell; M A Proschan; D G Simons-Morton Journal: JAMA Date: 2000-07-05 Impact factor: 56.272
Authors: Elizabeth Selvin; Spyridon Marinopoulos; Gail Berkenblit; Tejal Rami; Frederick L Brancati; Neil R Powe; Sherita Hill Golden Journal: Ann Intern Med Date: 2004-09-21 Impact factor: 25.391
Authors: L K Newby; W R Rutsch; R M Califf; M L Simoons; P E Aylward; P W Armstrong; L H Woodlief; K L Lee; E J Topol; F Van de Werf Journal: J Am Coll Cardiol Date: 1996-06 Impact factor: 24.094
Authors: Alexander T Schneider; Arthur M Pancioli; Jane C Khoury; Eric Rademacher; Alfred Tuchfarber; Rosemary Miller; Daniel Woo; Brett Kissela; Joseph P Broderick Journal: JAMA Date: 2003-01-15 Impact factor: 56.272
Authors: Billy A Caceres; Meghan Reading Turchioe; Anthony Pho; Theresa A Koleck; Ruth Masterson Creber; Suzanne B Bakken Journal: Am J Health Promot Date: 2020-06-19